Frontlight ResearchEarly access
Taking people in NetherlandsPhase 1
Tests MK-8294 alone in adults with advanced solid tumors
Tests MK-8294 alone in adults with advanced cancers of several kinds.
Key facts
- Who runs it
- Merck Sharp & Dohme LLC
- Where
- Amsterdam and Nijmegen, NetherlandsSee the 2 sites
- Trial code
- EU 2024-516870-31-00
- U1111-1311-2807
- Registry title
- A Phase 1 Open-label Study to Evaluate the Safety and Efficacy of MK‑8294 Monotherapy in Advanced Solid Tumors
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 21 people, planned
- Started
- 11 Jul 2025
- Expected to end
- 1 Jul 2027
- Type of study
- Interventional
- Record updated
- 28 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with certain advanced solid tumors, including endometrial, bladder, head and neck, esophageal, cervical and breast cancer. They would receive MK-8294 alone.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Advanced solid tumors (the record does not give more detail)
Main reasons for not taking part
- Healthy volunteers cannot join
Where in Netherlands
- Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis StichtingAmsterdam, NetherlandsTaking people
- Radboud universitair medisch centrum StichtingNijmegen, NetherlandsTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Plain-language title
- Tests MK-8294 alone in adults with advanced solid tumorsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 28 May 2026